Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alfa2b as first-line chemotherapy in elderly patients with multiple myeloma

Abstrakt

multiple myeloma, continuous prednisolone, conventional prednisolone with VMCP-interferon-alfa2b,elderly patients